Clinical and Molecular Spectrum of Liposarcoma.

Lee ATJ, Thway K, Huang PH, Jones RL. · 2018

Read Clinical and Molecular Spectrum of Liposarcoma. by Lee ATJ, Thway K, Huang PH, Jones RL. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5759315.txt.

Introduction

Lee and co-authors review the clinical and molecular range of liposarcoma. These rare tumors arise from fat forming tissue. Four main subtypes differ in behavior, drug response, and biology. Care choices now lean more on subtype traits than before.

Well-differentiated tumors grow slowly but often return at the same site. Dedifferentiated tumors turn aggressive and can spread and kill. Both share extra copies of chromosome 12 genes. Myxoid tumors carry a hallmark gene fusion. Pleomorphic tumors are complex and carry the worst outlook. New drugs aimed at subtype biology are in active study.

Catalog record

CREATORLee ATJ, Thway K, Huang PH, Jones RL.
YEAR2018
COLLECTIONPAPERS
FORMATTXT
FILE SIZE44 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5759315

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Clinical and Molecular Spectrum of Liposarcoma By Alex Thomas John Lee, Khin Thway, Paul H. Huang, Robin Lewis Jones Published in: Journal of Clinical Oncology DOI: 10.1200/JCO.2017.74.9598 ABSTRACT Liposarcomas are rare malignant tumors of adipocytic differentiation. The classification of liposarcomas into four principal subtypes reflects the distinct clinical behavior, treatment sensitivity, and underlying biology encompassed by these diseases. Increasingly, clinical management decisions and the development of investigational therapeutics are informed by an improved understanding of subtype-specific molecular pathology. Well-differentiated liposarcoma is the most common subtype and is associated with indolent behavior, local recurrence, and insensitivity to radiotherapy and chemotherapy. Dedifferentiated liposarcoma represents focal progression of well-differentiated disease into a more aggressive, metastasizing, and fatal malignancy. Both of these subtypes are characterized by recurrent amplifications within chromosome 12, resulting in the overexpression of disease-driving genes that have been the focus of therapeutic targeting. Myxoid liposarcoma is characterized by a pathognomonic chromosomal translocation that results in an oncogenic fusion protein, whereas pleomorphic liposarcoma is a karyotypically complex and especially poor-prognosis subtype that accounts for less than 10% of liposarcoma diagnoses. A range of novel pharmaceutical agents that aim to target liposarcoma-specific biology are under active investigation and offer hope of adding to the limited available treatment options for recurrent or inoperable disease. INTRODUCTION Liposarcomas (LPSs) are malignant tumors of adipocytic differentiation. They are among the more common soft tissue sarcoma (STS) subtypes, accounting for approximately 15% to 20% of all STSs.1 This disease is classified into four principal subtypes: well-differentiated LPS (WDLPS; also known as atypical lipomatous tumor), dedifferentiated LPS (DDLPS), myxoid LPS (MLPS), and pleomorphic LPS (PLPS; Table 1).2 An improved appreciation of the contrasting clinical behaviors of these subtypes, coupled with a growing understanding of their underlying molecular pathology, has led to increasingly subtype-tailored management and the development of novel systemic therapies. In this article, we review the key clinical, pathologic, and molecular characteristics of the LPS subtypes, summarize current management, and provide an overview of ongoing investigation of new therapeutic strategies. [Table: Clinical and Pathologic Features of the Four Principle Liposarcoma Subtypes] LPS SUBTYPES WDLPS and DDLPS WDLPS and DDLPS together account for the majority of LPSs and often coexist (WD/DDLPS). WDLPS can present as slowly growing masses in the retroperitoneum and proximal extremities. Distinguishing between peripheral WDLPS and much more commonly encountered benign adipocytic neoplasms may be challenging—lesions that are > 5cm in diameter, rapidly growing, and/or deep to superficial fascia warrant specialist evaluation. WDLPSs have no metastatic potential and are associated with an excellent outcome when complete excision is achieved. Local recurrence is more common when WDLPS arises in the retroperitoneum, mediastinum, or paratesticular region3 and is a cause of morbidity and mortality, as is the emergence of dedifferentiated disease. DDLPS is a high-grade and aggressive disease, arising most commonly within the retroperitoneum, and is associated with high rates of local and metastatic recurrence and disease-specific mortality that is six-fold that of WDLPS.4 Both WDLPS and DDLPS are typically radioinsensitive and chemoinsensitive.5 Shared morphologic and molecular features indicate that DDLPS occurs as a focal outgrowth within precursor WDLPS lesions, with 90% of DDLPS found within a primary WDLPS lesion and 10% within areas of locally recurrent WDLPS6 (Fig 1). [Figure: Radiologic appearance of retroperitoneal well-differentiated/dedifferentiated liposarcoma. Sagittal and coronal precontrast computed tomography images of a large liposarcoma expanding the retroperitoneum and encasing and displacing the left kidney. The blue arrow denotes a well-differentiated tumor, which shares a similar appearance to normal fat, extending inferiorly to the pelvic brim. The red arrow denotes a complex, ill-defined solid component of mixed attenuation, representing an area of dedifferentiated disease superior to left kidney.] Histologically, WDLPS appears as a proliferation of mature and variably pleomorphic adipocytes intersected by fibrous septa and containing single, enlarged, hyperchromatic nuclei (Fig 2A). DDLPS is characterized by more highly cellular areas of high-grade undifferentiated sarcoma typically transitioning abruptly within a background of WDLPS (Fig 2B). Supernumerary ring or giant rod chromosomes are found in both WDLPS and DDLPS. These consist of amplified segments of 12q13-15 that contain a number of cancer-related genes implicated in tumorigenesis.7 The most extensively studied of these are MDM2, an E3 ubiquitin protein ligase that acts as a key negative regulator of p53 and is amplified in nearly 100% of patients, and cyclin-dependent kinase 4 (CDK4), a key regulator of the G1/S cell cycle checkpoint that is coamplified with MDM2 in over 90% of patients8 (Fig 2C). Other genes commonly coamplified within the 12q13-15 amplicon include HMG2A, encoding an architectural transcription factor shown to be capable of cellular transformation, and TSPAN31, a gene of currently unknown function that has been shown to be amplified in multiple STS subtypes.9,10 YEATS4 and CPM are genes commonly coamplified within 12q13-15 that have been implicated in dedifferentiation.11,12 YEATS4 is a putative transcription factor required for physiologic suppression of p53 function and is implicated in oncogenesis across a number of cancers. In a large-scale genomic screening study of DDLPS cells, YEATS4 knockdown conferred greater antiproliferative effect than loss of MDM2 expression.11 CPM encodes carboxypeptidase M, a proteolytic enzyme with roles that include cleavage activation of growth factors, including epidermal growth factor. In a study of 12q-amplified LPS cell lines and xenografts, CPM knockout resulted in inhibition of growth, migration, and invasion, in association with downregulation of MAPK and PI3K pathway signaling.12 [Figure: Histologic appearance of liposarcoma subtypes. (A) Hematoxylin and eosin stain of well-differentiated liposarcoma (× 40). Tumor is composed of mature adipocytes in normal adipose tissue prominently intersected by sparsely cellular fibrous septa containing atypical, enlarged spindle cells with hyperchromatic nuclei. (B) Dedifferentiated liposarcoma (× 200). Hematoxylin and eosin stain illustrates typical appearance of dedifferentiated component as a high-grade spindle or pleomorphic sarcoma, with sheets of moderately atypical spindle cells with scattered mitotic figures and no apparent adipocytic differentiation. (C) Immunohistochemistry staining of dedifferentiated liposarcoma (× 40) shows diffuse and strong expression of CDK4, frequently coamplified with MDM2 in well-differentiated and dedifferentiated liposarcoma. (D) Myxoid liposarcoma (× 200). Relatively bland and uniform appearance, with small ovoid or spindle cells dispersed in prominent myxoid stroma alongside plexiform network of curvilinear, thin-walled blood vessels. In many areas, small lipoblasts with nuclear indentation and vacuolated cytoplasm are identifiable (arrows). (E) Round cell variant of myxoid liposarcoma (× 40). Markedly cellular distribution of round and ovoid cells containing rounded, hyperchromatic nuclei and minimal, largely amphophilic cytoplasm. As in this example, the absence of discernible myxoid stroma can lead to round cell myxoid liposarcoma being mistaken for other round cell neoplasms such as Ewing sarcoma. (F) Pleomorphic liposarcoma (× 200). Large, atypical multivacuolated lipoblasts with indented hyperchromatic nuclei are dispersed in a background of atypical spindle cells.] Although the somatic mutation rate has been shown to be low in WDLPS and DDLPS, the accumulation of additional chromosomal abnormalities seems to be central to the development of DDLPS.11,12 Recurrent amplifications of 1p32 and 6q23 are found exclusively in DDLPS and are associated with a worse prognosis.13 Overexpression of ASK1 (found in 6q23) and JUN (1p32) has been implicated in dedifferentiation through mechanisms that involve inhibition of peroxisome proliferator-activated receptor gamma, (PPARγ), a key mediator of adipocyte differentiation.14,15 LPS genomic profiling studies have also identified chromosomal deletions of tumor suppressor genes such as

Read the complete text